ALT: Altimmune, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 451.32
Enterprise Value ($M) 364.47
Book Value ($M) 150.40
Book Value / Share 2.80
Price / Book 3.00
NCAV ($M) 136.79
NCAV / Share 2.55
Price / NCAV 3.30

Profitability (mra)
Return on Invested Capital (ROIC) -0.52
Return on Assets (ROA) -0.38
Return on Equity (ROE) -0.42

Liquidity (mrq)
Quick Ratio 12.89
Current Ratio 12.89

Balance Sheet (mrq) ($M)
Current Assets 152.96
Assets 166.57
Liabilities 16.18
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
8 days ago 13G/A Nuveen Asset Management, LLC 2.88
8 days ago 13G/A Teachers Advisors, Llc 2.88
8 days ago 13G/A Tiaa Cref Investment Management Llc 2.88 -47.11
8 days ago 13G Ameriprise Financial Inc 7.79
8 days ago 13G/A Avidity Partners Management LP 0.00 -100.00
8 days ago 13G/A Tang Capital Partners Lp 5.10 1.83
9 days ago 13G/A Vanguard Group Inc 6.65 41.05
02-12 13G/A Janus Henderson Group Plc 0.00 -99.99
01-26 13G BlackRock Inc. 7.50 320.37
01-23 13G/A State Street Corp 1.89 26.18
2023-02-14 13G/A Cormorant Asset Management, LP 5.29 -1.89

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2023-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-02-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-02-21 547,104 2,445,180 22.37
2024-02-20 544,969 2,755,666 19.78
2024-02-16 722,725 3,627,482 19.92

(click for more detail)

Similar Companies
ADMA – ADMA Biologics, Inc. ALIM – Alimera Sciences, Inc.
ALPN – Alpine Immune Sciences, Inc. ANIP – ANI Pharmaceuticals, Inc.
APGE – Apogee Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io